← Leaderboards
Natalie S Callender
University Of Texas Hlth Sci Ctr San Ant
$0
Attributed
$0
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 1
By mechanism
M01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Eric K Rowinsky$9,623,858
- G David Roodman$13,528,230
- Gregory R Mundy$7,763,862
- Theresa A Guise$8,674,181
- Marc H Weiner$2,847,341
Others in their field
Top investigators on “Bone Disorder”
- Mary M Horowitz · Medical College Of Wisconsin$66,574,998
- Richard A Gibbs · Baylor College Of Medicine$64,966,866
- David Heimbrook · Leidos Biomedical Research, Inc.$55,577,351
- Steven R Cummings · University Of California San Francisco$28,658,587
- Electra D. Paskett · Ohio State University$25,614,484
- Joann Elisabeth Manson · Brigham And Women'S Hospital$23,589,300
Research focus
Bone DisorderBreast NeoplasmsCancer ComplicationClinical ResearchDiphosphonateDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationIntravenous AdministrationMultiple MyelomaSkeletal Disorder Chemotherapy
Grant awards (4)
ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERS$0
M01 · FY2002 · RR
ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERS$0
M01 · FY2002 · RR
ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERS$0
M01 · FY2001 · RR
ZOLEDRONATE VS AREDIA IN MULTIPLE MYELOMA/BREAST CANCER W /BONE DISORDERS$0
M01 · FY2000 · RR